Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Successful correction of metabolic acidosis is difficult to achieve inchronic kidney disease
Fernando Caravaca-Fontán; Rosa Díaz-Campillejo; Julián Valladares; Cristina López Arnaldo; Sergio Barroso; Enrique Luna; Francisco Caravaca;
Nefrologia (English Version). 2020;40:328-35
Cost-effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalemia in patients with chronic kidney disease or heart failure in Spain
Roberto Alcázar-Arroyo; María G Crespo-Leiro; Jordi Bover; Juan Oliva; Miren Sequera-Mutiozabal; Simona Gradari; Anisia Martínez-López; Blanca López-Chicheri; Neus Vidal-Vilar; Susana Aceituno; Marta Cobo;
Nefrologia (English Version). 2024;44:709-20
Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain
Patricia de Sequera; Ramón Bover; Yoana Ivanova-Markova; Alexandra Ivanova; Almudena González-Domínguez; Marta Valls; Verónica Campos;
Nefrologia (English Version). 2023;43:721-30